Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Profound Medical Q4 2023 GAAP EPS $(0.420) Misses $(0.330) Estimate, Sales $2.000M Beat $1.977M Estimate

Author: Benzinga Newsdesk | March 07, 2024 05:19pm
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.420) per share which missed the analyst consensus estimate of $(0.330) by 27.27 percent. The company reported quarterly sales of $2.000 million which beat the analyst consensus estimate of $1.977 million by 1.17 percent. This is a 53.85 percent increase over sales of $1.300 million the same period last year.

Posted In: PROF


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist